Telemedicine Technologies
develops e-Health solutions
to reinvent the organisation of healthcare in 5 key domains
Clinical Research
A flexible and modular offer that fully meets your needs…
Managed Access Programmes
Ethical and compliant mechanism for access to drugs…
Real-World Evidence & Registries
Support for healthcare professionals in the technical implementation of registry databases and set-up of monitoring indicators …
Patient Pathway
Plan, rationalise and standardise the care of your patients through medical protocols…
Investigator site Management
For an efficient Site Management in Clinical Research...
DISCOVER
eCRF • ePRO/eCOA • eConsent • IWRS • IMP Management Vigilance •
Imaging • eTMF • CTMS • rSDV • MAP
Do you want to learn more about our e-health solution? Just fill in the form and we will get back to you shortly
OUR SERVICES
Data Services
WE CARE FOR YOU DATA
Quality of Data through comprehensive clinical Data Management...
AI & Data Visualisation
ARTIFICIAL INTELLIGENCE EMPOWERING OUR SOLUTIONS AND DATA SERVICES
Advanced data processing based on machine learning and advanced statistics
Training
SKILLS TRANSFER & END-USER AUTONOMY
Our training courses have been awarded the national Qualiopi certification…
User Support
AVAILABLE IN FRENCH AND ENGLISH
User support is available in both French and English...
Hosting
SECURE OR HEALTH DATA HOSTING SERVICES
Secure hosting or Health Data Hosting services, at your convenience...
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
2 million +
patients
in database
50 000 +
users
worlwide
MEMBER OF
LATEST NEWSOUR NEWS >
May 22, 2023
Wednesday may 24 TELEMEDICINE TECHNOLOGIES will be present at SantExpo on the OVHcloud stand as a partner of the “Open Trusted Cloud” program. Our president Yoani Matsakis will be representing Telemedicine Technologies, and wil intervene next to Mathieu Godart, CTO and co-founder of SÊMEIA and Emmanuel MEYRIEUX, Client Security manager at OVHcloud. Throughout the day you […]
May 22, 2023
Fierce Biotech The FDA seems to be satisfied that Pfizer’s RSV vaccine is safe and effective for administration in pregnant women to protect infants from severe disease. The agency’s confidence was revealed in briefing documents filed ahead of an advisory committee meeting set for Thursday. The Vaccines and Related Biological Products Advisory Committee will consider […]
May 22, 2023
Trial Site News The World Health Organisation (WHO) decided Thursday May 4, 2023, to end the COVID-19 public health emergency of international concern (PHEIC). TrialSite cautions that this is a provisional (temporary) status while WHO considers its forward-looking options (2023-2025). Importantly, in “The COVID-19 Emergency is Over, Sort of,” TrialSite reports that in America some […]